To harness the precision and adaptability of bacteriophages to develop safe, effective therapies for chronic, hard-to-treat, orphan infections like Mycobacterium abscessus complex pulmonary disease (MABC-PD)
Explore our phage therapy expanded access program
Technologies for generating superphages and optimizing phage cocktails are poised to overcome antibiotic resistance and resolve microbiome dysbiosis
Phage Therapy Today Podcast Episode
